B-Cell CD40 Expression by Flow Cytometry, Blood
NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
Evaluating patients for hyper-IgM type 3 (HIGM3) syndrome due to defects in CD40, typically seen in patients <10 years of age
Assessing B-cell immune competence in other clinical contexts, including autoimmunity, malignancy and transplantation
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
CD40 by Flow, QL, B